The Biotech Sector is Positioned for a Big 2022 Rebound
The biotechnology sector was one of the worst underperformers in 2021, but this niche of the financial markets could see a big rebound in 2022.
The Biotech Sector is Positioned for a Big 2022 Rebound
Synbio: The Next Big Thing in Biotech
Having attracted $9 billion in fresh capital during H1 2021, the “synthetic biology” sector is rapidly becoming one of the hottest emerging technologies in the market.